TRAVERE THERAPEUTICS (BILE ACID PRODUCT PORTFOLIO)
Summary
Travere’s bile acid product portfolio includes Cholbam® (cholic acid) and Chenodal® (chenodiol), two medications addressing rare diseases in high-need settings.
Deals Overview
Total Deals1
Valued Deals1
Total Value£367M
Avg. Deal Size£367M
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
No credit card required
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.